Androgen regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA expression and receptor binding in the rat brain

Experimental Neurology

Volumn 214, Issue 1, 2008, Pages 62-68

  Weiser, Michael J ^a   Goel, Nirupa ^b   Sandau, Ursula S ^a   Bale, Tracy L ^b   Handa, Robert J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Androgen; Anxiety; CRH; Gonadal steroids; HPA axis; Stress

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTANOLONE PROPIONATE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; FLUTAMIDE; MESSENGER RNA;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; FEMALE; FETUS; FOREBRAIN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; IN VITRO STUDY; MALE; MOOD DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTUM PELLUCIDUM;

ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; AUTORADIOGRAPHY; CELLS, CULTURED; DIHYDROTESTOSTERONE; FEMALE; FLUTAMIDE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NEURONS; ORCHIECTOMY; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPTAL NUCLEI;

EID: 53949119802     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.07.013     Document Type: Article

References (67)

1. Adler A., Vescovo P., Robinson J.K., and Kritzer M.F. Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats. Neuroscience 89 (1999) 939-954
2. Amore M. Partial androgen deficiency and neuropsychiatric symptoms in aging men. J Endocrinol. Invest. 28 (2005) 49-54
3. Angold A., and Worthman C.W. Puberty onset of gender differences in rates of depression: a developmental, epidemiologic and neuroendocrine perspective. J. Affect. Disord. 29 (1993) 145-158
4. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160 (1999) 1-12
5. Bale T.L., and Vale W.W. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci. 23 (2003) 5295-5301
6. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 525-557
7. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., and Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24 (2000) 410-414
8. Banker G.A., and Cowan W.M. Rat hippocampal neurons in dispersed cell culture. Brain Res. 126 (1977) 342-397
9. Bao A.M., Fischer D.F., Wu Y.H., Hol E.M., Balesar R., Unmehopa U.A., Zhou J.N., and Swaab D.F. A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol. Psychiatry 11 (2006) 567-576
10. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J. Psychiatry Neurosci. 29 (2004) 185-193
11. Bingaman E.W., Magnuson D.J., Gray T.S., and Handa R.J. Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy. Neuroendocrinology 59 (1994) 228-234
12. Brewer G.J. Isolation and culture of adult rat hippocampal neurons. J. Neurosci. Methods 71 (1997) 143-155
13. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35 (1993) 567-576
14. Campeau S., and Watson S.J. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J. Neuroendocrinol. 9 (1997) 577-588
15. Catalano R.D., Kyriakou T., Chen J., Easton A., and Hillhouse E.W. Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol. Endocrinol. 17 (2003) 395-410
16. Chen A., Perrin M., Brar B., Li C., Jamieson P., Digruccio M., Lewis K., and Vale W. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol. Endocrinol. 19 (2005) 441-458
17. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
18. de Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev., Neurosci. 6 (2005) 463-475
19. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
20. Duncan G.E., Johnson K.B., and Breese G.R. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J. Neurosci. 13 (1993) 3932-3943
21. Edinger K.L., and Frye C.A. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology 30 (2005) 418-430
22. Ehlert U., Gaab J., and Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 57 (2001) 141-152
23. Foradori C.D., Werner S.B., Sandau U.S., Clapp T.R., and Handa R.J. Activation of the androgen receptor alters the intracellular calcium response to glutamate in primary hippocampal neurons and modulates sarco/endoplasmic reticulum calcium ATPase 2 transcription. Neuroscience 149 (2007) 155-164
24. Frye C.A., and Seliga A.M. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn. Affect. Behav. Neurosci. 1 (2001) 371-381
25. Frye C.A., and Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm. Behav. 44 (2003) 319-326
26. Grigoriadis D.E., Liu X.J., Vaughn J., Palmer S.F., True C.D., Vale W.W., Ling N., and De Souza E.B. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Mol. Pharmacol. 50 (1996) 679-686
27. Haas D.A., and George S.R. Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus. Brain Res. Bull. 20 (1988) 361-367
28. Handa R.J., Pak T.R., Kudwa A.E., Lund T.D., and Hinds L. An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. Horm. Behav. (2007)
29. Handa R.J., Nunley K.M., Lorens S.A., Louie J.P., McGivern R.F., and Bollnow M.R. Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors. Physiol. Behav. 55 (1994) 117-124
30. Herman J.P., and Mueller N.K. Role of the ventral subiculum in stress integration. Behav. Brain Res. 174 (2006) 215-224
31. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., and Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 24 (2003) 151-180
32. Heuser I., Bissette G., Dettling M., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Nemeroff C.B., and Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress. Anxiety 8 (1998) 71-79
33. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17 (1996) 187-205
34. Ing N.H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod. 72 (2005) 1290-1296
35. Isogawa K., Akiyoshi J., Tsutsumi T., Kodama K., Horinouti Y., and Nagayama H. Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain. J. Psychopharmacol. 17 (2003) 409-413
36. Jacobson L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12 (1991) 118-134
37. Kerr J.E., Allore R.J., Beck S.G., and Handa R.J. Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology 136 (1995) 3213-3221
38. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., and Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005) 617-627
39. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., and Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 415-419
40. Kornstein S.G. Gender differences in depression: implications for treatment. J. Clin. Psychiatry 58 Suppl 15 (1997) 12-18
41. Lim M.M., Nair H.P., and Young L.J. Species and sex differences in brain distribution of corticotropin-releasing factor receptor subtypes 1 and 2 in monogamous and promiscuous vole species. J. Comp. Neurol. 487 (2005) 75-92
42. Lino-de-Oliveira C., de Oliveira R.M., Padua Carobrez A., de Lima T.C., del Bel E.A., and Guimaraes F.S. Antidepressant treatment reduces Fos-like immunoreactivity induced by swim stress in different columns of the periaqueductal gray matter. Brain Res. Bull. 70 (2006) 414-421
43. Llewellyn A.M., Stowe Z.N., and Nemeroff C.B. Depression during pregnancy and the puerperium. J. Clin. Psychiatry 58 Suppl 15 (1997) 26-32
44. Lund T.D., Munson D.J., Haldy M.E., and Handa R.J. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 16 (2004) 272-278
45. Lund T.D., Munson D.J., Haldy M.E., and Handa R.J. Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse. Neurosci. Lett. 365 (2004) 43-47
46. Makino S., Asaba K., Nishiyama M., and Hashimoto K. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Neuroendocrinology 70 (1999) 160-167
47. Makino S., Nishiyama M., Asaba K., Gold P.W., and Hashimoto K. Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am. J. Physiol. 275 (1998) R1138-1145
48. Markovic D., Punn A., Lehnert H., and Grammatopoulos D.K. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol. Endocrinol. 22 (2008) 689-706
49. Ni X., and Nicholson R.C. Steroid hormone mediated regulation of corticotropin-releasing hormone gene expression. Front. Biosci. 11 (2006) 2909-2917
50. Nishiyama M., Makino S., Asaba K., and Hashimoto K. Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat. J. Neuroendocrinol. 11 (1999) 307-314
51. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press, San Diego
52. Reul J.M., and Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2 (2002) 23-33
53. Risold P.Y., and Swanson L.W. Connections of the rat lateral septal complex. Brain Res. Brain Res. Rev. 24 (1997) 115-195
54. Risold P.Y., and Swanson L.W. Chemoarchitecture of the rat lateral septal nucleus. Brain Res. Brain Res. Rev. 24 (1997) 91-113
55. Roy B.N., Reid R.L., and Van Vugt D.A. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Endocrinology 140 (1999) 2191-2198
56. Seale J.V., Wood S.A., Atkinson H.C., Harbuz M.S., and Lightman S.L. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J. Neuroendocrinol. 16 (2004) 989-998
57. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294 (1990) 76-95
58. Slob A.K., Bogers H., and van Stolk M.A. Effects of gonadectomy and exogenous gonadal steroids on sex differences in open field behaviour of adult rats. Behav. Brain Res. 2 (1981) 347-362
59. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., and Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
60. Steciuk M., Kram M., Kramer G.L., and Petty F. Decrease in stress-induced c-Fos-like immunoreactivity in the lateral septal nucleus of learned helpless rats. Brain Res. 822 (1999) 256-259
61. Suemaru S., Darlington D.N., Akana S.F., Cascio C.S., and Dallman M.F. Ventromedial hypothalamic lesions inhibit corticosteroid feedback regulation of basal ACTH during the trough of the circadian rhythm. Neuroendocrinology 61 (1995) 453-463
62. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 (1998) 162-166
63. Vamvakopoulos N.C., and Chrousos G.P. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92 (1993) 1896-1902
64. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
65. Varghese F.P., and Brown E.S. The hypothalamic-pituitary-adrenal axis in major depressive disorder: a brief primer for primary care physicians. Prim. Care Companion J. Clin. Psychiat. 3 (2001) 151-155
66. Viau V., and Meaney M.J. Testosterone-dependent variations in plasma and intrapituitary corticosteroid binding globulin and stress hypothalamic-pituitary-adrenal activity in the male rat. J. Endocrinol. 181 (2004) 223-231
67. Weissman M.M., Bland R., Joyce P.R., Newman S., Wells J.E., and Wittchen H.U. Sex differences in rates of depression: cross-national perspectives. J. Affect. Disord. 29 (1993) 77-84